The FDA slapped Quest Diagnostics' ($DGX) Focus Diagnostics unit with a Class I recall over some of its lab examination kits after the tools produced inaccurate test ...
Quest Diagnostics' ($DGX) Focus Diagnostics unit snagged an FDA OK for its quick strep test, a notch in Quest's belt as it looks to revive sluggish sales and generate ...
As the 2014-2015 flu season begins, Focus Diagnostics, the products business of Quest Diagnostics (NYSE: DGX), today announced that its Simplexa™ Flu A/B & RSV Direct Kit has received FDA clearance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback